{"entity":{"type":"insider","cik":"0001806431","url":"/insider/0001806431","json_url":"/insider/0001806431.json","name":"Hykes Andrew","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":141,"n_filings":41,"first":"2020-05-27","last":"2024-12-20","span_basis":"filed_date"},"name_variants":[{"name":"Hykes Andrew","source":"filing","n_filings":41,"first_seen":"2020-05-27","last_seen":"2024-12-20"}],"transactions":[{"id":2174018,"accession":"0001127602-24-029927","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-24-029927","line_url":"/filing/0001127602-24-029927","is_derivative":false,"issuer_cik":"0001531048","issuer_name":"Inari Medical, Inc.","issuer_ticker":"NARI","issuer_name_source":null,"issuer_url":"/issuer/0001531048","owner_cik":"0001806431","owner_name":"Hykes Andrew","owner_display_name":"Hykes Andrew","owner_url":"/insider/0001806431","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":55.29,"price_display":"55.29","price_state":"stated","total_value":165870.0,"total_display":"165,870.00","total_whole":"165,870","shares_owned_after":439910.0,"shares_owned_after_display":"439,910","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-20","filed_date":"2024-12-20","scope":"insider","n_lines":2},{"id":2054110,"accession":"0001127602-24-027912","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-24-027912","line_url":"/filing/0001127602-24-027912#line-1","is_derivative":false,"issuer_cik":"0001531048","issuer_name":"Inari Medical, Inc.","issuer_ticker":"NARI","issuer_name_source":null,"issuer_url":"/issuer/0001531048","owner_cik":"0001806431","owner_name":"Hykes Andrew","owner_display_name":"Hykes Andrew","owner_url":"/insider/0001806431","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":50.83,"price_display":"50.83","price_state":"stated","total_value":152490.0,"total_display":"152,490.00","total_whole":"152,490","shares_owned_after":442310.0,"shares_owned_after_display":"442,310","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-20","filed_date":"2024-11-22","scope":"insider"},{"id":2504212,"accession":"0001127602-24-026168","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-24-026168","line_url":"/filing/0001127602-24-026168#line-1","is_derivative":false,"issuer_cik":"0001531048","issuer_name":"Inari Medical, Inc.","issuer_ticker":"NARI","issuer_name_source":null,"issuer_url":"/issuer/0001531048","owner_cik":"0001806431","owner_name":"Hykes Andrew","owner_display_name":"Hykes Andrew","owner_url":"/insider/0001806431","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":50.0,"price_display":"50.00","price_state":"stated","total_value":150000.0,"total_display":"150,000.00","total_whole":"150,000","shares_owned_after":445310.0,"shares_owned_after_display":"445,310","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-29","filed_date":"2024-10-31","scope":"insider"},{"id":3241868,"accession":"0001127602-24-022796","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-24-022796","line_url":"/filing/0001127602-24-022796#line-1","is_derivative":false,"issuer_cik":"0001531048","issuer_name":"Inari Medical, Inc.","issuer_ticker":"NARI","issuer_name_source":null,"issuer_url":"/issuer/0001531048","owner_cik":"0001806431","owner_name":"Hykes Andrew","owner_display_name":"Hykes Andrew","owner_url":"/insider/0001806431","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":50.0,"price_display":"50.00","price_state":"stated","total_value":150000.0,"total_display":"150,000.00","total_whole":"150,000","shares_owned_after":452532.0,"shares_owned_after_display":"452,532","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-20","filed_date":"2024-08-22","scope":"insider"},{"id":2783907,"accession":"0001127602-24-020966","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-24-020966","line_url":"/filing/0001127602-24-020966#line-1","is_derivative":false,"issuer_cik":"0001531048","issuer_name":"Inari Medical, Inc.","issuer_ticker":"NARI","issuer_name_source":null,"issuer_url":"/issuer/0001531048","owner_cik":"0001806431","owner_name":"Hykes Andrew","owner_display_name":"Hykes Andrew","owner_url":"/insider/0001806431","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":55.23,"price_display":"55.23","price_state":"stated","total_value":165690.0,"total_display":"165,690.00","total_whole":"165,690","shares_owned_after":455252.0,"shares_owned_after_display":"455,252","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-22","filed_date":"2024-07-24","scope":"insider"},{"id":3122038,"accession":"0001127602-24-020038","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001127602-24-020038","line_url":"/filing/0001127602-24-020038#line-5","is_derivative":false,"issuer_cik":"0001531048","issuer_name":"Inari Medical, Inc.","issuer_ticker":"NARI","issuer_name_source":null,"issuer_url":"/issuer/0001531048","owner_cik":"0001806431","owner_name":"Hykes Andrew","owner_display_name":"Hykes Andrew","owner_url":"/insider/0001806431","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":50.08,"price_display":"50.08","price_state":"stated","total_value":150240.0,"total_display":"150,240.00","total_whole":"150,240","shares_owned_after":462474.0,"shares_owned_after_display":"462,474","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-01","filed_date":"2024-07-03","scope":"insider"},{"id":2783242,"accession":"0001127602-24-017012","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-24-017012","line_url":"/filing/0001127602-24-017012#line-1","is_derivative":false,"issuer_cik":"0001531048","issuer_name":"Inari Medical, Inc.","issuer_ticker":"NARI","issuer_name_source":null,"issuer_url":"/issuer/0001531048","owner_cik":"0001806431","owner_name":"Hykes Andrew","owner_display_name":"Hykes Andrew","owner_url":"/insider/0001806431","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":50.0,"price_display":"50.00","price_state":"stated","total_value":150000.0,"total_display":"150,000.00","total_whole":"150,000","shares_owned_after":465474.0,"shares_owned_after_display":"465,474","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-28","filed_date":"2024-05-30","scope":"insider"},{"id":7947290,"accession":"0001127602-23-027915","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-23-027915","line_url":"/filing/0001127602-23-027915","is_derivative":false,"issuer_cik":"0001531048","issuer_name":"Inari Medical, Inc.","issuer_ticker":"NARI","issuer_name_source":null,"issuer_url":"/issuer/0001531048","owner_cik":"0001806431","owner_name":"Hykes Andrew","owner_display_name":"Hykes Andrew","owner_url":"/insider/0001806431","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":37448.0,"shares_display":"37,448","price_per_share":59.82368858149968,"price_display":"59.82","price_state":"stated","total_value":2240277.49,"total_display":"2,240,277.49","total_whole":"2,240,277","shares_owned_after":451232.0,"shares_owned_after_display":"451,232","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-16","filed_date":"2023-11-17","scope":"insider","n_lines":2},{"id":8205998,"accession":"0001127602-23-022961","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001127602-23-022961","line_url":"/filing/0001127602-23-022961","is_derivative":false,"issuer_cik":"0001531048","issuer_name":"Inari Medical, Inc.","issuer_ticker":"NARI","issuer_name_source":null,"issuer_url":"/issuer/0001531048","owner_cik":"0001806431","owner_name":"Hykes Andrew","owner_display_name":"Hykes Andrew","owner_url":"/insider/0001806431","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":36676.0,"shares_display":"36,676","price_per_share":66.11487212345948,"price_display":"66.11","price_state":"stated","total_value":2424829.05,"total_display":"2,424,829.05","total_whole":"2,424,829","shares_owned_after":493642.0,"shares_owned_after_display":"493,642","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-16","filed_date":"2023-08-18","scope":"insider","n_lines":4},{"id":8536230,"accession":"0001127602-23-016225","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001127602-23-016225","line_url":"/filing/0001127602-23-016225","is_derivative":false,"issuer_cik":"0001531048","issuer_name":"Inari Medical, Inc.","issuer_ticker":"NARI","issuer_name_source":null,"issuer_url":"/issuer/0001531048","owner_cik":"0001806431","owner_name":"Hykes Andrew","owner_display_name":"Hykes Andrew","owner_url":"/insider/0001806431","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18760.0,"shares_display":"18,760","price_per_share":69.19,"price_display":"69.19","price_state":"stated","total_value":1298004.4,"total_display":"1,298,004.40","total_whole":"1,298,004","shares_owned_after":516289.0,"shares_owned_after_display":"516,289","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-17","filed_date":"2023-05-18","scope":"insider","n_lines":3},{"id":8536223,"accession":"0001127602-23-016225","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001127602-23-016225","line_url":"/filing/0001127602-23-016225","is_derivative":false,"issuer_cik":"0001531048","issuer_name":"Inari Medical, Inc.","issuer_ticker":"NARI","issuer_name_source":null,"issuer_url":"/issuer/0001531048","owner_cik":"0001806431","owner_name":"Hykes Andrew","owner_display_name":"Hykes Andrew","owner_url":"/insider/0001806431","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17916.0,"shares_display":"17,916","price_per_share":70.87,"price_display":"70.87","price_state":"stated","total_value":1269706.92,"total_display":"1,269,706.92","total_whole":"1,269,707","shares_owned_after":532521.0,"shares_owned_after_display":"532,521","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-16","filed_date":"2023-05-18","scope":"insider","n_lines":3},{"id":8292167,"accession":"0001127602-23-010958","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-23-010958","line_url":"/filing/0001127602-23-010958","is_derivative":false,"issuer_cik":"0001531048","issuer_name":"Inari Medical, Inc.","issuer_ticker":"NARI","issuer_name_source":null,"issuer_url":"/issuer/0001531048","owner_cik":"0001806431","owner_name":"Hykes Andrew","owner_display_name":"Hykes Andrew","owner_url":"/insider/0001806431","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9000.0,"shares_display":"9,000","price_per_share":64.29,"price_display":"64.29","price_state":"stated","total_value":578610.0,"total_display":"578,610.00","total_whole":"578,610","shares_owned_after":554083.0,"shares_owned_after_display":"554,083","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-20","filed_date":"2023-03-21","scope":"insider","n_lines":2},{"id":8358504,"accession":"0001127602-23-006508","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-23-006508","line_url":"/filing/0001127602-23-006508#line-2","is_derivative":false,"issuer_cik":"0001531048","issuer_name":"Inari Medical, Inc.","issuer_ticker":"NARI","issuer_name_source":null,"issuer_url":"/issuer/0001531048","owner_cik":"0001806431","owner_name":"Hykes Andrew","owner_display_name":"Hykes Andrew","owner_url":"/insider/0001806431","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9000.0,"shares_display":"9,000","price_per_share":55.19,"price_display":"55.19","price_state":"stated","total_value":496710.0,"total_display":"496,710.00","total_whole":"496,710","shares_owned_after":130595.0,"shares_owned_after_display":"130,595","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-21","filed_date":"2023-02-22","scope":"insider"},{"id":8430593,"accession":"0001127602-23-002143","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001127602-23-002143","line_url":"/filing/0001127602-23-002143","is_derivative":false,"issuer_cik":"0001531048","issuer_name":"Inari Medical, Inc.","issuer_ticker":"NARI","issuer_name_source":null,"issuer_url":"/issuer/0001531048","owner_cik":"0001806431","owner_name":"Hykes Andrew","owner_display_name":"Hykes Andrew","owner_url":"/insider/0001806431","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9000.0,"shares_display":"9,000","price_per_share":61.90322222222222,"price_display":"61.90","price_state":"stated","total_value":557129.0,"total_display":"557,129.00","total_whole":"557,129","shares_owned_after":93146.0,"shares_owned_after_display":"93,146","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-20","filed_date":"2023-01-24","scope":"insider","n_lines":3},{"id":6691939,"accession":"0001127602-22-028160","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001127602-22-028160","line_url":"/filing/0001127602-22-028160","is_derivative":false,"issuer_cik":"0001531048","issuer_name":"Inari Medical, Inc.","issuer_ticker":"NARI","issuer_name_source":null,"issuer_url":"/issuer/0001531048","owner_cik":"0001806431","owner_name":"Hykes Andrew","owner_display_name":"Hykes Andrew","owner_url":"/insider/0001806431","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9000.0,"shares_display":"9,000","price_per_share":68.4952,"price_display":"68.50","price_state":"stated","total_value":616456.8,"total_display":"616,456.80","total_whole":"616,457","shares_owned_after":102998.0,"shares_owned_after_display":"102,998","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-20","filed_date":"2022-12-22","scope":"insider","n_lines":3},{"id":6747960,"accession":"0001127602-22-026266","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-22-026266","line_url":"/filing/0001127602-22-026266","is_derivative":false,"issuer_cik":"0001531048","issuer_name":"Inari Medical, Inc.","issuer_ticker":"NARI","issuer_name_source":null,"issuer_url":"/issuer/0001531048","owner_cik":"0001806431","owner_name":"Hykes Andrew","owner_display_name":"Hykes Andrew","owner_url":"/insider/0001806431","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9000.0,"shares_display":"9,000","price_per_share":77.65501777777777,"price_display":"77.66","price_state":"stated","total_value":698895.16,"total_display":"698,895.16","total_whole":"698,895","shares_owned_after":115987.0,"shares_owned_after_display":"115,987","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-21","filed_date":"2022-11-22","scope":"insider","n_lines":2},{"id":6930595,"accession":"0001127602-22-024305","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001127602-22-024305","line_url":"/filing/0001127602-22-024305","is_derivative":false,"issuer_cik":"0001531048","issuer_name":"Inari Medical, Inc.","issuer_ticker":"NARI","issuer_name_source":null,"issuer_url":"/issuer/0001531048","owner_cik":"0001806431","owner_name":"Hykes Andrew","owner_display_name":"Hykes Andrew","owner_url":"/insider/0001806431","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9000.0,"shares_display":"9,000","price_per_share":72.33406,"price_display":"72.33","price_state":"stated","total_value":651006.54,"total_display":"651,006.54","total_whole":"651,007","shares_owned_after":123963.0,"shares_owned_after_display":"123,963","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-20","filed_date":"2022-10-24","scope":"insider","n_lines":4},{"id":6817388,"accession":"0001127602-22-022216","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-22-022216","line_url":"/filing/0001127602-22-022216#line-1","is_derivative":false,"issuer_cik":"0001531048","issuer_name":"Inari Medical, Inc.","issuer_ticker":"NARI","issuer_name_source":null,"issuer_url":"/issuer/0001531048","owner_cik":"0001806431","owner_name":"Hykes Andrew","owner_display_name":"Hykes Andrew","owner_url":"/insider/0001806431","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":70.0,"price_display":"70.00","price_state":"stated","total_value":350000.0,"total_display":"350,000.00","total_whole":"350,000","shares_owned_after":130991.0,"shares_owned_after_display":"130,991","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-06","filed_date":"2022-09-08","scope":"insider"},{"id":6342505,"accession":"0001127602-22-020367","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001127602-22-020367","line_url":"/filing/0001127602-22-020367","is_derivative":false,"issuer_cik":"0001531048","issuer_name":"Inari Medical, Inc.","issuer_ticker":"NARI","issuer_name_source":null,"issuer_url":"/issuer/0001531048","owner_cik":"0001806431","owner_name":"Hykes Andrew","owner_display_name":"Hykes Andrew","owner_url":"/insider/0001806431","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":78.671866,"price_display":"78.67","price_state":"stated","total_value":393359.33,"total_display":"393,359.33","total_whole":"393,359","shares_owned_after":136052.0,"shares_owned_after_display":"136,052","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-01","filed_date":"2022-08-03","scope":"insider","n_lines":4},{"id":6463986,"accession":"0001127602-22-019006","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001127602-22-019006","line_url":"/filing/0001127602-22-019006#line-3","is_derivative":false,"issuer_cik":"0001531048","issuer_name":"Inari Medical, Inc.","issuer_ticker":"NARI","issuer_name_source":null,"issuer_url":"/issuer/0001531048","owner_cik":"0001806431","owner_name":"Hykes Andrew","owner_display_name":"Hykes Andrew","owner_url":"/insider/0001806431","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":70.31,"price_display":"70.31","price_state":"stated","total_value":351550.0,"total_display":"351,550.00","total_whole":"351,550","shares_owned_after":140991.0,"shares_owned_after_display":"140,991","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-05","filed_date":"2022-07-06","scope":"insider"},{"id":6577454,"accession":"0001127602-22-017136","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-22-017136","line_url":"/filing/0001127602-22-017136#line-1","is_derivative":false,"issuer_cik":"0001531048","issuer_name":"Inari Medical, Inc.","issuer_ticker":"NARI","issuer_name_source":null,"issuer_url":"/issuer/0001531048","owner_cik":"0001806431","owner_name":"Hykes Andrew","owner_display_name":"Hykes Andrew","owner_url":"/insider/0001806431","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":70.078,"price_display":"70.08","price_state":"stated","total_value":350390.0,"total_display":"350,390.00","total_whole":"350,390","shares_owned_after":146984.0,"shares_owned_after_display":"146,984","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-07","filed_date":"2022-06-09","scope":"insider"},{"id":6603417,"accession":"0001562180-22-003739","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001562180-22-003739","line_url":"/filing/0001562180-22-003739","is_derivative":false,"issuer_cik":"0001531048","issuer_name":"Inari Medical, Inc.","issuer_ticker":"NARI","issuer_name_source":null,"issuer_url":"/issuer/0001531048","owner_cik":"0001806431","owner_name":"Hykes Andrew","owner_display_name":"Hykes Andrew","owner_url":"/insider/0001806431","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":79.670256,"price_display":"79.67","price_state":"stated","total_value":398351.28,"total_display":"398,351.28","total_whole":"398,351","shares_owned_after":153247.0,"shares_owned_after_display":"153,247","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-02","filed_date":"2022-05-04","scope":"insider","n_lines":5},{"id":6132378,"accession":"0001562180-22-003258","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001562180-22-003258","line_url":"/filing/0001562180-22-003258#line-7","is_derivative":false,"issuer_cik":"0001531048","issuer_name":"Inari Medical, Inc.","issuer_ticker":"NARI","issuer_name_source":null,"issuer_url":"/issuer/0001531048","owner_cik":"0001806431","owner_name":"Hykes Andrew","owner_display_name":"Hykes Andrew","owner_url":"/insider/0001806431","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3394.0,"shares_display":"3,394","price_per_share":91.63,"price_display":"91.63","price_state":"stated","total_value":310992.22,"total_display":"310,992.22","total_whole":"310,992","shares_owned_after":158590.0,"shares_owned_after_display":"158,590","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-01","filed_date":"2022-04-05","scope":"insider"},{"id":6132376,"accession":"0001562180-22-003258","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001562180-22-003258","line_url":"/filing/0001562180-22-003258#line-6","is_derivative":false,"issuer_cik":"0001531048","issuer_name":"Inari Medical, Inc.","issuer_ticker":"NARI","issuer_name_source":null,"issuer_url":"/issuer/0001531048","owner_cik":"0001806431","owner_name":"Hykes Andrew","owner_display_name":"Hykes Andrew","owner_url":"/insider/0001806431","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2607.0,"shares_display":"2,607","price_per_share":89.76,"price_display":"89.76","price_state":"stated","total_value":234004.32,"total_display":"234,004.32","total_whole":"234,004","shares_owned_after":164377.0,"shares_owned_after_display":"164,377","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-01","filed_date":"2022-04-05","scope":"insider"},{"id":6132372,"accession":"0001562180-22-003258","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001562180-22-003258","line_url":"/filing/0001562180-22-003258#line-5","is_derivative":false,"issuer_cik":"0001531048","issuer_name":"Inari Medical, Inc.","issuer_ticker":"NARI","issuer_name_source":null,"issuer_url":"/issuer/0001531048","owner_cik":"0001806431","owner_name":"Hykes Andrew","owner_display_name":"Hykes Andrew","owner_url":"/insider/0001806431","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1606.0,"shares_display":"1,606","price_per_share":92.1,"price_display":"92.10","price_state":"stated","total_value":147912.6,"total_display":"147,912.60","total_whole":"147,913","shares_owned_after":156984.0,"shares_owned_after_display":"156,984","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-01","filed_date":"2022-04-05","scope":"insider"}],"collapsed":true,"next_cursor":"2022-04-01|6132372","ledger_fault":false,"count":{"value":141,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":4,"open_market":true},{"code":"S","label":"Open-market sale","n":137,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":141},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001531048","name":"Inari Medical, Inc.","url":"/issuer/0001531048","role":"Director, Officer (President and CEO)","n_filings":41,"first_seen":"2020-05-27","last_seen":"2024-12-20"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001806431","retrieved_at":"2026-08-27T07:03:36+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}